Kilitch Drugs (India) Limited has informed the Exchange regarding 'Postponement of Right credit of right issue shares'.
KILITCH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kilitch Drugs has postponed the credit and listing dates for its recently concluded Rights Issue. The issue of 13,98,463 equity shares at Rs. 357 per share (face value Rs. 10) was offered in a 2:23 ratio, raising about Rs. 49.93 crore. The credit of shares, originally scheduled for August 25, 2025, will now happen on August 26, 2025, and listing on NSE/BSE has shifted from August 26 to August 28, 2025. The basis of allotment was finalised on August 25, 2025. The record date of July 15, 2025 remains unchanged.
This is a minor administrative delay of 1-2 days in share credit and listing timelines, with no change to the issue size, price, or ratio. Shareholders who applied will receive their allotted shares a day later, and the stock will start trading on the exchanges from August 28 instead of August 26 — a routine procedural update with no material impact on shareholders.